Form D · Biotechnology
BIOTHERYX, INC.
San Diego, CA · CIK 0001458857
Offering snapshot reported Jun 2, 2021 · SEC filing
- Reported sold
- $92.1M Offering amount: $100M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 2, 2021 | Initial | $92,107,638 | No comparison | Not reported | SEC filing |
| May 5, 2015 | Initial | $500,000 | No comparison | 4 | SEC filing |
| Sep 23, 2014 | Initial | $150,000 | No comparison | 3 | SEC filing |
| Jun 10, 2014 | Initial | $1,000,000 | No comparison | 10 | SEC filing |
| Mar 9, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-401380
Source: Form D, filed Jun 2, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kyle W.H. Chan | Executive |
| Kyle Chan, Ph D | Executive |
| Louis De Gennaro | Director |
| Louis De Gennaro, Ph D | Director |
| Christopher A. Devine | Director |
| Jaime A. Donadio | Executive |
| Frank Mercurio | Executive |
| Frank Mercurio, Ph D | Executive |
| Jack Noelke | Director |
| David I. Stirling | Director, Executive |
| David Stirling, Ph D | Director, Executive |
| Dung Thai | Executive |
| Robert F. Williamson | Director, Executive |
| Lawrence Zaslow | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7966 Arjons Dr., Suite D
San Diego, CA, 92126
San Diego, CA, 92126